Evolutionary Genomics, Inc.

Businessfiled

Evolutionary Genomics, Inc. operates in Other, based in CASTLE ROCK.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Evolutionary Genomics, Inc. has raised $2.4M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.0M on 2014-03-17.

Most recent recorded round closed around 2014-03-17.

Valuation (modeled)modeled

Provath models Evolutionary Genomics, Inc. at approximately $37M (range $1.8M–$292M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.14× the median modeled value of Seed Other companies in 2013–2015 (998 peers) — value vs value, same stage and era. Within the normal band (114% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 21 months.

Last raise 12.3 yr ago; this sector typically re-raises about every 11 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 4.6× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 53% of Other peers (25015 compared).

Modeled value ranks above 67% of those peers.

Closest niche peers: Bodri Capital Management, LLC, as Trustee under that certain Declaration of Trust dated December 17, 2015, 76826774, Llc, 76826773, Llc, 76826772, Llc, EW Investor, LLC.

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.